CEL Sci Corp: Form 10-Q for the period ended Jun 30, 2015
Filed with the SEC on Aug 7, 2015 and accepted by EDGAR at Aug 7, 2015, 20:32 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2015-04-01 to 2015-06-30 | $5.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2014-10-01 to 2015-06-30 | $15.6m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2015-04-01 to 2015-06-30 | −$8.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2014-10-01 to 2015-06-30 | −$26.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2015-04-01 to 2015-06-30 | $41.6k | us-gaap:InterestExpense |
| Interest expense | 9 months2014-10-01 to 2015-06-30 | $124.9k | us-gaap:InterestExpense |
| Net income | 3 months2015-04-01 to 2015-06-30 | −$4.4m | us-gaap:NetIncomeLoss |
| Net income | 9 months2014-10-01 to 2015-06-30 | −$24.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2015-04-01 to 2015-06-30 | −$0.06 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2014-10-01 to 2015-06-30 | −$0.32 | us-gaap:EarningsPerShareBasicAndDiluted |
| Basic EPS | 3 months2015-04-01 to 2015-06-30 | −$0.05 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2015-04-01 to 2015-06-30 | 85,134,107 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2014-10-01 to 2015-06-30 | −$18.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2014-10-01 to 2015-06-30 | $56.6k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2015-06-30 | $11.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-06-30 | $14.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2015-06-30 | $21.5m | us-gaap:Assets |
| Current liabilities | At period end2015-06-30 | $5.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2015-06-30 | $17.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2015-06-30 | $3.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001354488-15-003627. Last ingested by Listed: Oct 24, 2026, 14:55 ET. Listed shows no prices and gives no investment advice.